Wilson Sonsini Goodrich & Rosati advised SR One on the deal.Simcha Therapeutics, a biotechnology company developing cytokine-based cancer immunotherapies, announced the closing of a $40 million…
Simcha Therapeutics’ $40 Million Series B Financing
![](https://globallegalchronicle.com/wp-content/uploads/2022/02/simcha-therapeutics-40-million-series-b-financing_61f8cca2ba391-480x360.jpeg)
Wilson Sonsini Goodrich & Rosati advised SR One on the deal.Simcha Therapeutics, a biotechnology company developing cytokine-based cancer immunotherapies, announced the closing of a $40 million…
You must be a Standard 1 Year member to access this content.
…
You must be a Standard 1 Year member to access this content.